ELOVL2 and renal cell carcinoma: They showed that ELOVL2 ablation might suppress the production of docosahexaenoic acid (DHA) and LDs in renal cancer cells, suggesting that ELOVL2 overexpression may promote LD production through endogenous DHA production in RCC.